Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
9,821,037
Publication Date
11-21-2017
Abstract
A compound is provided which comprises at least a portion of an amino acid linker-domain from squalene synthase. In alternative forms, the compound can include the amino-acid linker-domain from various fungus, including S. cerevisiae or the compound can be the functional equivalent and/or mimics an amino acid linker-domain from squalene synthase. A pharmaceutical composition includes the compound and may further include a pharmaceutical carrier. A method is provided for treating or controlling cholesterol metabolism and ergosterol metabolism in non-fungal organisms. One method includes a therapeutic treatment in humans by administering a therapeutically effective amount of the compound or pharmaceutical composition, to a patient in need of treatment, therefrom.
Assignees
University of Kentucky Research Foundation (Lexington, KY, US)
Application Number
14/257,598
Filing Date
04/21/2014
Recommended Citation
Chappell, Joseph; Niehaus, Tom D.; and Linscott, Kristin Brooke, "Compounds and Method of Use as Anti-Infection Compounds and Therapeutic Agents to Regulate Cholesterol Metabolism" (2017). Molecular and Cellular Biochemistry Faculty Patents. 24.
https://uknowledge.uky.edu/biochem_patents/24
